Kenvue INC Form 4 insider transactions

NYSE
Kenvue Inc.'s CEO, Kirk Perry, filed an amended Form 4 to correct an administrative error in shares withheld for taxes related to vested Restricted Stock Units.
NYSE
Kenvue's Group President North America, Carlos De Jesus, was granted 50,842 Restricted Stock Units and 483,870 Stock Options, vesting over three years.
NYSE
Kenvue's Chief Corporate Affairs Officer, Russell Dyer, had RSU vesting accelerated on December 15, 2025, citing a pending transaction with Kimberly-Clark Corporation.
NYSE
Kenvue CEO Kirk Perry reported accelerated vesting of Restricted Stock Units and subsequent tax-related share sales, driven by a pending transaction with Kimberly-Clark Corporation.
NYSE
Kenvue Group President APAC, Anindya Dasgupta, filed an amended Form 4 to correct an inadvertent omission of 32,649 Restricted Stock Units.
NYSE
Kenvue's Chief Scientific Officer, Caroline Tillett, accelerated the vesting of restricted stock units totaling 33,922.64 shares, primarily to mitigate Section 280G tax impacts related to a pending transaction with Kimberly-Clark Corporation.
NYSE
Kenvue's General Counsel, Matthew Orlando, reported accelerated vesting of restricted stock units and subsequent tax-related share dispositions, linked to a pending transaction with Kimberly-Clark Corporation.
NYSE
Kenvue Director Jeffrey C. Smith, through Starboard Value LP, acquired over 6.3 million shares of Kenvue common stock in two transactions in December 2025.
NYSE
Kimberly-Clark and Kenvue filed a preliminary joint proxy statement/prospectus with the SEC for their proposed transaction, seeking stockholder approval.
NYSE
Kenvue Inc. and Kimberly-Clark have initiated formalized integration planning for their anticipated combination, expected in the second half of 2026, appointing Russ Torres as Integration Lead.
NYSE
Kenvue Director Jeffrey C. Smith filed a Form 4, reporting his indirect beneficial ownership of 20.9 million common shares and the acquisition of 1,451 Deferred Share Units.
NYSE
Kimberly-Clark's leadership discusses the strategic rationale behind the Kenvue acquisition, emphasizing synergy potential and a plan to revitalize Kenvue's brands while maintaining momentum in its core business.
NYSE
Kenvue Inc. Director Sarah Hofstetter acquired 1,451 Deferred Share Units as part of a compensation deferral plan.
NYSE
Kenvue's General Counsel, Matthew Orlando, reported the vesting and subsequent tax-related sale of company common stock.
NYSE
Kenvue Inc.'s Group President for EMEA & LA, Carlton Lawson, increased his direct beneficial ownership by 1,779 common shares following the vesting of restricted stock units.
NYSE
Kenvue's Chief Operations Officer, Meredith Stevens, reported the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations.
NYSE
Kenvue Director Richard E. Allison Jr. acquired 1,451 Deferred Share Units, increasing his beneficial ownership to over 35,900 units.
NYSE
Kenvue's Chief People Officer, Luani Alvarado, reported the vesting of restricted stock units and subsequent shares withheld for tax obligations.
NYSE
Kenvue's Chief Scientific Officer, Caroline Tillett, reported the acquisition of common stock through RSU vesting and subsequent tax-related dispositions.
NYSE
Kimberly-Clark's DTS leadership discusses the Kenvue acquisition, leadership changes, and strategic project resequencing amidst a focus on growth and employee well-being.
NYSE
Kenvue's Chief People Officer, Luani Alvarado, reported the conversion of Restricted Stock Units into common stock and subsequent tax-related share dispositions.
NYSE
Kenvue's Chief Operations Officer, Meredith Stevens, reported the vesting of Restricted Stock Units and subsequent tax-related share dispositions.
NYSE
Kimberly-Clark's CHRO announced a proposed transaction with Kenvue, aiming to create a preeminent global health and wellness leader.
NYSE
Kenvue Inc. announced its planned combination with Kimberly-Clark Corporation, aiming to create a leading consumer health and personal care powerhouse by the second half of 2026.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. have announced a proposed transaction, with an infographic posted on November 14, 2025, detailing the merger.
NYSE
Kenvue Inc. issued an employee communication clarifying the impact of its proposed transaction with Kimberly-Clark Corporation on compensation, benefits, and equity.
NYSE
Kenvue announces an agreement to be acquired by Kimberly-Clark, creating a $32 billion global health and wellness leader.
NYSE
Kimberly-Clark Corporation and Kenvue Inc. have announced a proposed transaction, with further details to be filed with the SEC.
NYSE
Kimberly-Clark's Chief Strategy Officer announced a proposed transaction with Kenvue, aiming to create a preeminent global health and wellness leader.
NYSE
Kimberly-Clark Corporation announced its acquisition of Kenvue Inc. for over $40 billion, aiming to create the second-largest consumer packaged goods company globally, despite an immediate 14% stock drop.